Molecule One is a tech-bio company based in Warsaw, Poland on a mission to solve the unpredictability of organic chemistry so drugs can be made faster.
We leverage our diverse background in organic chemistry, artificial intelligence and software to build solutions that speak to and empower chemists.
To date Molecule.one raised $5m in pre-seed & seed rounds, has worked with 6 of the world's largest biopharma companies, and in 2019 was the first CEE startup ever to launch at Startup Battlefield TechCrunch Disrupt San Francisco.
Molecule One is a fast-growing company. If you want to work with us to make our vision happen please get in touch.
We are a collection of talented, ambitious, and innovative people working to improve drug discovery.
"Solve the unpredictability of chemical synthesis and you will transform the way drugs are made."
Piotr Byrski, CEO
Co-founders Piotr Byrski, MD (L) , and Paweł Włodarczyk-Pruszyński, MD (R)
We are a team of 24 specialist with a background in academia and expertise in AI and chemistry.
What connects us on the molecular level is that we are all driven by the company’s mission: to help make medicines faster.
Our key strength is our culture focused on diverse thinking and leveraging expertise in different fields. We do not to work in silos or treat any discipline as superior, but rather work as equals towards our mission.
We run internal chemistry lessons and machine learning seminars, as well as cooperate with external consultants who complement us with their unique know-how and experience.
The scientific method is at the core of our company. We trust our team to find the best way to solve a challenge by taking risks and experimenting.
On a daily basis, we try to minimize the number of mandatory meetings in favour of uninterrupted focused work time. We also regularly allocate time for our employees to work on things they choose, whatever their motive.